111C Axelrod, Rita - Thomas Jefferson University - Thomas Jefferson University
Dr. Axelrod

Rita Axelrod, MD

Contact Dr. Axelrod

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience
  2. Journal of clinical oncology
  3. Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer
  4. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests
  5. T 1A90 reatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy
  6. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
  7. E5501: Phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
  8. Current management of locally advanced head and neck cancer: The combination of chemotherapy with locoregional treatments
  9. A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma
  10. Sarcoidosis mimicking metastatic bone disease in head and neck cancer
  11. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
  12. The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801
  13. An economic model to value companion diagnostics in non-small-cell lung cancer
  14. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field Radiotherapy and concurrent chemotherapy
  15. Uncommon Tumors of the Oral Cavity and Adjacent Structures
  16. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer
  17. Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
  18. Endovascular management of carotid blowout
  19. A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
  20. A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: A trial of the Eastern Cooperative Oncology Group (E1303)
0